Akers Biosciences Announces Q1 2018 Earnings
AKERS BIOSCIENCES INC COMMON S (AKER)
US:NASDAQ Investor Relations:
akersbio.com/investor-center
Company Research
Source: GlobeNewswire
THOROFARE, N.J, July 13, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, reports its financial results for the first quarter ended March 31, 2018. A Form 10-Q containing the full financial statements is available for viewing on the Company's website at www.akersbio.com or www.sec.gov. Q1 Financial Summary: Total revenue $302,475 (Q1 2017: $667,250) Revenue from flagship PIFA Heparin PF/4 Rapid Assay products $259,983 (Q1 2017: $560,921) – the Company experienced lower yields in the process of extracting antigen used to produce these products, resulting in production under target levels, and backorders Gross profit margin 2% (Q1 2017: 61%) Costs associated with the low antigen yields and steps to remediate the issue significantly affected the direct costs of production and the fixed nature of key components of the indirect production costs impacted the margin during t
Show less
Read more
Impact Snapshot
Event Time:
AKER
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AKER alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AKER alerts
High impacting AKERS BIOSCIENCES INC COMMON S news events
Weekly update
A roundup of the hottest topics